Evidence map›Paper›PMID 41640714›Full record

ArticleBiomaterials research2026

Ultrasound-Activated Nanoplatform Counteracts Triple-Negative Breast Cancer via Remodeling Intratumoral Microbiota-Metabolism and Inducing Ferroptosis.

Shuao Li, Yuxiu Gao, Danni Jiang, Xiaoyu Wu, Yanan Feng, Fang Chen, Ningning He, Shangyong Li, Luxia Jing, Cheng Zhao

Abstract read
In one paragraph

Article in Biomaterials research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shuao LiDepartment of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Yuxiu GaoDepartment of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Danni JiangDepartment of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Xiaoyu WuSchool of Basic Medicine, Qingdao Medical College, Qingdao University, Qingdao 266071, China.
Yanan FengDepartment of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Fang ChenDepartment of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Ningning HeSchool of Basic Medicine, Qingdao Medical College, Qingdao University, Qingdao 266071, China.
Shangyong LiDepartment of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Luxia JingDepartment of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Cheng ZhaoDepartment of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.ORCID https://orcid.org/0009-0002-7821-7755

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triple-negative breast cancer (TNBC) remains therapeutically challenging owing to the paucity of broadly effective molecular targets. Piezoelectric nanomaterials that generate localized electric fields and reactive oxygen species under ultrasound (US) stimulation have emerged as a promising strategy for TNBC therapy. Here, we developed a US-activatable nanoplatform (HN-T/BT@Lip) in which toyocamycin-loaded CaCO

Identifiers

PMID41640714
PMCPMC12864655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.